HILE(SH:603718)2024-10-30 10:07Financial Performance - The company's operating revenue for Q3 2024 was ¥66,829,604.35, a decrease of 11.73% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was ¥5,048,439.00, an increase of 171.72% year-on-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was ¥8,590,852.92, up 189.71% from the previous year[2] - The company achieved a turnaround from loss to profit, with a net profit attributable to shareholders of RMB 15,142,746.18 for the reporting period, and a net profit of RMB 50,521,189.17 year-to-date[12] - The net profit excluding non-recurring gains and losses for the reporting period was RMB 18,685,160.10, and RMB 25,908,938.42 year-to-date[12] - Net profit for the first nine months of 2024 was CNY 15,408,989.98, a decline of 76.4% compared to CNY 65,068,599.32 in the previous year[20] - The company recorded a profit before tax of CNY 7,277,269.64, down from CNY 77,829,494.88 in the previous year[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,623,715,669.10, a decrease of 2.05% compared to the end of the previous year[3] - The total liabilities decreased from CNY 482,957,571.38 to CNY 398,045,570.51, reflecting a reduction of approximately 17.6%[17] - The company’s total assets decreased from CNY 1,657,749,783.34 to CNY 1,623,715,669.10, indicating a decline of about 2.1%[17] - The total equity attributable to shareholders increased to CNY 1,272,862,793.23 from CNY 1,216,978,966.74, marking a growth of 4.6%[17] Cash Flow - The company reported a net cash flow from operating activities of ¥21,682,523.91 for the year-to-date, an increase of 137.75% compared to the same period last year[2] - The net cash flow from operating activities for the first three quarters of 2024 is ¥21,682,523.91, a significant improvement from a net outflow of ¥57,441,944.39 in the same period of 2023[23] - Total cash inflow from investment activities is ¥559,112,248.43, compared to ¥725,772,545.78 in the previous year, indicating a decrease of approximately 22.9%[23] - The net cash flow from investment activities is -¥35,827,215.57, an improvement from -¥103,442,918.83 in the same period last year[23] - Cash inflow from financing activities is ¥58,413,429.00, down from ¥219,942,000.00 in the previous year, reflecting a decrease of about 73.5%[23] - The net cash flow from financing activities is -¥45,420,566.76, contrasting with a positive net flow of ¥166,631,735.55 in the same period of 2023[23] - The total cash and cash equivalents at the end of the period is ¥77,522,211.08, down from ¥162,306,087.44 at the end of the same period last year[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 31,802[9] - A cash dividend of RMB 0.0287 per share (including tax) was distributed, totaling RMB 18,881,730, based on a total share capital of 657,900,000 shares[13] - The largest shareholder, Shanghai Haoyuan Venture Capital Development Co., Ltd., holds 34.38% of the shares, totaling 226,197,938 shares[11] - The second-largest shareholder, Fang Zhangle, holds 4.47% of the shares, totaling 29,433,351 shares[11] - The company has not reported any changes in the top 10 shareholders due to securities lending activities[12] - The total number of shares held by the top 10 unrestricted shareholders is 326,000,000 shares[11] Expenses - Total operating costs increased to CNY 210,114,237.84, up 15.9% from CNY 181,325,947.83 year-over-year[19] - The company reported a significant increase in management expenses, which rose to CNY 62,962,578.79, compared to CNY 26,481,179.39 in the same period last year[19] - Research and development expenses were CNY 16,830,160.27, slightly down from CNY 18,474,271.48 year-over-year[19] Other Financial Metrics - The weighted average return on equity for Q3 2024 was 0.41%, an increase of 1.05 percentage points year-on-year[3] - The basic earnings per share for Q3 2024 was ¥0.01, reflecting a year-on-year increase of 171.72%[3] - The company recognized a total of ¥37,653,794.64 in stock incentive expenses for the year-to-date, impacting net profit significantly[4] - Non-recurring gains and losses included a loss of ¥7,041,899.27 from the disposal of non-current assets for the year-to-date[5] - Other comprehensive income after tax attributable to the parent company was CNY 1,568,638.59, compared to CNY 7,804,209.30 in the same period last year[20] Investments and Acquisitions - The company completed the acquisition of 55% equity in Shaanxi Ruisheng Biotechnology Co., Ltd. and the sale of 30% equity in Cayman WuXi AppTec, with the transaction approved on October 16, 2024[12] - The company has ongoing investments in various financial products, with a total of ¥4 billion in floating income products and net value products, indicating active financial management strategies[14] Inventory and Current Assets - As of September 30, 2024, the company's cash and cash equivalents decreased to ¥77.53 million from ¥140.74 million as of December 31, 2023, representing a decline of approximately 44.8%[15] - The total current assets increased significantly to ¥1.17 billion from ¥562.55 million, indicating a growth of approximately 108.5%[15] - The company's inventory decreased to ¥84.79 million from ¥102.82 million, reflecting a reduction of about 17.5%[15] - Short-term borrowings increased to ¥60.91 million from ¥50 million, marking a rise of 21.8%[16] - Accounts payable decreased to ¥21.88 million from ¥30.14 million, a reduction of approximately 27.5%[16] - The company reported a significant increase in other receivables, rising to ¥106.48 million from ¥4.91 million, an increase of approximately 2,067.5%[15] - The company has maintained goodwill at ¥225.33 million, unchanged from the previous period, indicating stability in its intangible assets[16] - The company has a deferred tax asset of ¥21.71 million, up from ¥18.60 million, reflecting an increase of approximately 15.3%[16]